‘High-Value’ Part D Drugs Get Boost In Medicare Advantage Payment Pilot
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS announces five-year pilot program to test value-based insurance designs in Medicare Advantage plans, which might include reduced cost-sharing for Part D drugs that treat chronic conditions.